U.S. Capital Markets Stock News

On July 22, 2026, Casey's General Stores filed its definitive proxy statement urging shareholders to vote against a proposal to let investors owning at least 15% of outstanding shares call special shareholder meetings at the September 2, 2026 annual meeting. At the same time, analysts are watching for the company’s upcoming fiscal 2027 first-quarter earnings, where expectations of double-digit profit growth highlight the tension between governance debates and operational execution. We’ll now...

After a sharp 37.8% gain over the past month, WEX now sits near US$188, and the key issue for investors is that this strong share price move sits alongside valuation checks that lean more on the expensive side than on clear value. The 37.8% move over the past month puts recent momentum front and center, which can leave less room for error if expectations do not hold up. Growth in WEX's B2B payments and fleet fraud prevention offerings can support higher earnings expectations. However, any...

Energy infrastructure is back in focus after drone attacks at Egypt’s Damietta Port disrupted a key LNG hub and raised fresh questions about security near the Suez Canal. For investors, this kind of headline risk can quickly reshape how stocks exposed to LNG, pipelines, and shipping are priced, as the market weighs supply disruption, insurance costs, and geopolitical risk. This article looks at 3 stocks from an Energy Infrastructure & Security screener that appear more directly exposed to the...

Pinnacle Financial Partners (PNFP) is back in focus after reporting second quarter 2026 net income of US$328 million, compared to US$159 million a year earlier, alongside updated common and preferred dividend declarations. See our latest analysis for Pinnacle Financial Partners. The recent earnings and dividend updates have arrived against a backdrop of steady gains for Pinnacle Financial Partners, with the share price at US$104.74, a 7 day share price return of 7.58% and a 1 year total...

Teladoc Health stock is coming off a very weak 5 year run, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both point to the shares screening as undervalued relative to those fundamentals. Teladoc Health has seen its share price decline 93.9% over the past 5 years, which puts long term returns sharply at odds with the current view that the stock may now be priced below its underlying value. The launch plans for the Teladoc One...

The market finally cut Unum Group some slack today. After drifting lower over the past month, the stock is up about 2% in live trading as investors digest a Q2 report that leans firmly on earnings power rather than headline revenue. The core message is simple. Adjusted operating earnings per share of US$2.16 and a consolidated adjusted operating return on equity near 15.9% give bulls fresh ammunition, even as recent net profit margins over the last year sit well below the prior year. The...

Arm Holdings stock has surged 96.0% year to date, yet its low value score suggests the current price does not screen as a clear bargain on the broader checks. Year to date, Arm Holdings has gained 96.0%, which sets a high bar for any further upside to be justified by fundamentals. Strong positioning in AI servers and royalty growth can support higher earnings expectations, while recent share price volatility and concerns around smartphone demand may limit how much investors are willing to...

Nabors Industries stock is edging higher today, up about 2% in active trading, even though the fresh quarter again showed a loss at the earnings per share line. The market is reacting less to that headline loss and more to what sat behind it. Adjusted earnings before interest, tax, depreciation and amortization came in at roughly US$222 million with margins above 27%, ahead of management’s own targets. For a stock that has fallen over the past quarter, investors are now weighing that stronger...

After a 47.6% return over the past year, Target now sits in a zone where its recent share price strength and mixed valuation checks leave the current US$145.90 level looking less like an obvious bargain and more like a price that needs closer scrutiny. Target's 47.6% 1 year return puts recent momentum front and center, which raises the question of how much of the good news is already reflected in the share price. The appointment of former 7 Eleven CEO Joe DePinto to Target's board may...

Earlier this year, Remitly Global, Inc. launched the Remitly Global Card, a cross-border account that lets customers get paid, spend, save, and send money internationally from one platform, with features such as preferred FX rates, no foreign transaction fees, global ATM access, multi-currency and USDC balances, and instant card-to-card transfers. A distinctive angle is Remitly Global Card Membership, which pairs access to an open-end line of credit and Smart Rate FX protection with perks...

Artificial intelligence stocks sit at the crossroads of several forces that investors are watching in 2026. Global growth signals are mixed, central banks continue to weigh inflation data, and energy costs remain a key swing factor. At the same time, demand for AI related chips, software, cloud and large language models links into real investment and trade flows across the US, Europe and Asia. This article uses an AI Stocks screener focused on companies directly involved in the ChatGPT and...

DXP Enterprises (DXPE) shares declined 7.54% in the latest session, lagging the S&P 500 and industrial peers as investors focused on the company’s upcoming earnings report and what it might reveal about demand trends. See our latest analysis for DXP Enterprises. The recent 1 day share price decline of 7.54% and 7 day share price decline of 14.13% follow a strong year to date share price return of 37.56%. The 5 year total shareholder return of 369.37% highlights the impact of longer term...

Sun Communities, Inc. has now reported its second-quarter 2026 results, with sales of US$422.7 million and revenue of US$484.6 million, but a net loss of US$992.7 million that translated into a basic loss per share of US$8.06. Beneath the headline loss, the company delivered core funds from operations of US$1.84 per share above guidance, raised its full-year outlook, authorized a US$1 billion share repurchase program, and completed the sale of its U.K. business to concentrate on its North...

Tyler Technologies (TYL) is in focus after reporting second quarter 2026 results and updating investors on a sizable share repurchase program, providing fresh data points to assess the stock. See our latest analysis for Tyler Technologies. The earnings beat and expanded buyback plan have come after a mixed stretch for Tyler Technologies, with a 17.3% 7 day share price return and its 1 year total shareholder return down 39.87% at a recent price of $333.50. That pattern suggests short term...

Clearway Energy earnings expectations set the tone Clearway Energy (CWEN) is in focus as investors watch for June 2026 quarterly results, with expectations for lower earnings alongside higher revenue. These results could influence how the stock trades in the near term. See our latest analysis for Clearway Energy. Clearway Energy’s recent share price performance has been weak, with the stock down 23.74% on a 90 day share price return basis, even though the 3 year total shareholder return is...

agilon health (AGL) drew investor attention after announcing that Chief Technology Officer Girish Venkatachaliah will leave his role on August 1, 2026, and will remain as a consultant through the end of the year. See our latest analysis for agilon health. The CTO transition comes at a volatile moment for agilon health, with the share price falling 6.54% over the last day and 22.71% over the last week, yet still showing a very large year to date share price return of around 4.5x and a 94.05%...

Arrowhead Pharmaceuticals (ARWR) is back in focus after two late stage RNA interference programs hit important milestones. Plozasiran delivered positive Phase 3 topline data in severe hypertriglyceridemia, and zodasiran’s Phase 3 YOSEMITE trial has now completed enrollment. See our latest analysis for Arrowhead Pharmaceuticals. The recent late stage cardiometabolic data appear to be feeding into Arrowhead Pharmaceuticals’ share price momentum, with a 30 day share price return of 7.11% and a...

AbCellera Biologics Inc. recently announced a collaboration with Vertex Pharmaceuticals to research, develop, manufacture, and commercialize multispecific T-cell engagers for autoimmune diseases and other conditions, with AbCellera receiving US$28 million in upfront payments plus eligibility for milestones and tiered royalties. This agreement broadens the use of AbCellera’s T-cell engager platform while allowing Vertex to fund all R&D, potentially adding a new stream of partnered, downstream...

CubeSmart (CUBE) has reaffirmed its income return profile, with the Board of Trustees declaring a quarterly dividend of $0.53 per common share for the period ending September 30, 2026. See our latest analysis for CubeSmart. The reaffirmed dividend sits alongside a steady pick up in CubeSmart's share price momentum, with a 7 day share price return of 3.19% and a year to date share price return of 19.86%, while the 1 year total shareholder return is 9.09%. If CubeSmart's steady income and price...

Big tech’s heavy spending on artificial intelligence is suddenly under the microscope after Meta shares dropped 11% on plans to lift annual spending to as much as US$145b, even as quarterly profit fell 14% to US$6b and free cash flow slid to a five year low of US$784 million. With Google also facing questions around the pay off from high AI budgets, many investors are rethinking which companies might benefit or struggle as this theme plays out. This article looks at three business...

Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this environment, identifying undervalued stocks can be a strategic approach for investors seeking opportunities where current prices may not fully reflect future growth potential.

Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential alignment of interests between management and shareholders.

Over the last 7 days, the U.S. market has dropped 2.6%, but it has risen by 14% over the past year, with earnings projected to grow annually by 17% in the coming years. In light of these conditions, investors may find value in penny stocks—an investment area that still holds relevance despite being an older term. By focusing on companies with solid financials and potential for growth, investors can uncover opportunities among smaller or less-established firms that might offer both stability...

In the second quarter of 2026, AMC Entertainment Holdings reported revenue of US$1,596.7 million, up from US$1,397.9 million a year earlier, while its net loss widened to US$11.4 million and basic loss per share from continuing operations moved to US$0.02. The company also highlighted the exceptional performance of “The Odyssey,” which delivered the strongest two-week IMAX run in history, underscoring how premium formats and sold-out high-end showtimes are becoming a critical driver of...